Insider Trading Activity - Column Group IV GP LP

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Column Group IV GP LP

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-04-05 Sale	2024-04-08 8:04 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP 10% Owner	21,743,413	$0	$0	2,000 (Indirect Direct)	View
2023-11-15 Purchase	2023-11-17 4:30 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	22,631	$0.6852	$15,507	21,743,413 (Indirect Direct)	View
2023-01-30 Purchase	2023-02-01 4:50 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	184,272	$4.9986	$921,110	21,720,782 (Indirect Direct)	View
2023-01-23 Purchase	2023-01-25 4:35 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	9,900	$4.9994	$49,494	21,536,510 (Indirect Direct)	View
2023-01-19 Purchase	2023-01-23 4:22 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	38,139	$4.9976	$190,603	21,526,610 (Indirect Direct)	View
2023-01-12 Purchase	2023-01-17 4:34 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	5,378	$4.9466	$26,603	21,488,471 (Indirect Direct)	View
2023-01-10 Purchase	2023-01-12 4:37 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	309,070	$4.7865	$1,479,359	21,483,093 (Indirect Direct)	View
2022-12-12 Purchase	2022-12-14 4:29 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	300	$4.9767	$1,493	21,174,023 (Indirect Direct)	View
2022-11-21 Purchase	2022-11-23 4:17 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	40,327	$4.9988	$201,588	21,173,723 (Indirect Direct)	View
2022-11-03 Purchase	2022-11-07 4:20 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	139,148	$4.9187	$684,427	21,133,396 (Indirect Direct)	View
2022-10-27 Purchase	2022-10-31 5:19 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	76,877	$4.8602	$373,638	20,994,248 (Indirect Direct)	View
2022-10-25 Purchase	2022-10-27 6:55 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	123,820	$4.8088	$595,428	20,917,371 (Indirect Direct)	View
2022-06-09 Purchase	2022-06-13 5:05 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	984,161	$13.5	$13,286,174	18,143,374 (Indirect Direct)	View
2022-06-02 Purchase	2022-06-06 4:44 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	34,200	$13.03	$445,739	18,110,897 (Indirect Direct)	View
2022-05-31 Purchase	2022-06-02 4:28 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	153,806	$13.46	$2,069,667	18,109,768 (Indirect Direct)	View
2022-05-26 Purchase	2022-05-31 5:02 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	22,911	$13.49	$309,035	18,104,692 (Indirect Direct)	View
2022-05-25 Purchase	2022-05-27 4:29 pm	RAPT Therapeutics Inc.	RAPT	COLUMN GROUP II LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC 10% Owner	1,900	$12.45	$23,664	3,189,178 (Indirect Direct)	View
2022-05-24 Purchase	2022-05-26 4:13 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	61,120	$13.42	$819,948	18,103,936 (Indirect Direct)	View
2022-05-23 Purchase	2022-05-25 4:20 pm	RAPT Therapeutics Inc.	RAPT	COLUMN GROUP II LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC 10% Owner	26,550	$12.19	$323,745	3,189,115 (Indirect Direct)	View
2022-05-19 Purchase	2022-05-23 4:14 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	39,700	$13.36	$530,454	18,101,919 (Indirect Direct)	View
2022-05-17 Purchase	2022-05-19 4:39 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	151,699	$13.33	$2,022,004	18,100,609 (Indirect Direct)	View
2022-05-13 Purchase	2022-05-17 4:22 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	162,531	$2.6327	$427,891	18,095,603 (Indirect Direct)	View
2022-05-11 Purchase	2022-05-13 5:32 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	166,350	$11.43	$1,902,032	18,090,240 (Indirect Direct)	View
2022-05-10 Purchase	2022-05-12 5:29 pm	RAPT Therapeutics Inc.	RAPT	COLUMN GROUP II LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC 10% Owner	1,250,000	$10.67	$13,339,375	3,188,239 (Indirect Direct)	View
2022-05-09 Purchase	2022-05-11 6:14 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	114,440	$10.95	$1,252,982	18,084,750 (Indirect Direct)	View
2022-01-24 Purchase	2022-01-26 7:14 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	849,701	$0	$0	18,080,973 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-12-23 Other	2024-12-23 5:59 pm	N/A N/A	RAPT Therapeutics Inc.	RAPT	COLUMN GROUP II LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Former 10% Owner	2,951,425	$0	7,376,864 (Direct)	View
2024-04-05 Other	2024-04-08 8:04 pm	N/A N/A	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP 10% Owner	1,000	$0	2,000 (Indirect)	View

Insider Trading & Ownership - Column Group IV GP LP